DIRECT BIOLOGICS LLC

In News

Exosomes: Company Spotlights from "A" to "Z" - BioInformant

BioInformant - Nov 04, 2025

Direct Biologics’ Phase 1 Clinical Trial Seeks to Treat Crohn Disease With Extracellular Vesicles - CGTLive®

CGTLive® - Dec 04, 2023

FibroBiologics (Nasdaq: FBLG) prices $1.5M direct offering at $0.335 with private warrants - Stock Titan

Stock Titan - Nov 24, 2025

Direct Biologics Appoints Dr. Amy Lightner as Chief Medical Officer - citybiz

citybiz - Feb 15, 2023

Houston-based SPAC Good Works II aims to take Austin-based Direct Biologics public - The Business Journals

The Business Journals - Sep 29, 2022

Direct Biologics Announces New Advanced Tool in Regenerative Medicine with Launch of AmnioWrap™ Placental Allograft - Newswire :) Press Release Distribution

Newswire :) Press Release Distribution - Jan 12, 2021

CDMO Samsung Biologics telegraphs spinoff of biosim unit - Fierce Pharma

Fierce Pharma - May 22, 2025

Direct Biologics Announces Significant Survival Benefit with ExoFlo™ in its Phase 2 Randomized Clinical Trial - BioInformant

BioInformant - Jul 13, 2023

Direct Biologics LLC announced that it expects to receive $100 million in funding from IB Investments 1 LLC, and other investors - marketscreener.com

marketscreener.com - Sep 26, 2022

Acute Respiratory Distress Syndrome (ARDS) Market Set for Robust Growth, Forecast to Reach US$ 2.53 Billion by 2033 - vocal.media

vocal.media - Sep 25, 2025

Direct Biologics Gets New Look in Noncompete, Trade Secrets Case - Bloomberg Law News

Bloomberg Law News - Apr 04, 2023

Bioclinica Partners with Direct Biologics to Provide Interactive Response Technology (IRT) Solution for COVID-19 Study - PR Newswire

PR Newswire - Sep 09, 2020

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment